Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients

Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients

<i>Background</i>: Early-phase neoadjuvant trials have demonstrated promising results in the utility of upfront immunotherapy in locally advanced stage III melanoma and unresected nodal disease. Secondary to these results and the COVID-19 pandemic, this patient population, traditionally...

Full description

Bibliographic Details
Main Authors: Katie Kinaschuk, Tina Cheng, Thomas Brenn, J. Gregory McKinnon, Claire Temple-Oberle
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Current Oncology
Subjects:
neoadjuvant therapy
melanoma
COVID-19
Online Access:https://www.mdpi.com/1718-7729/30/5/335

Internet

https://www.mdpi.com/1718-7729/30/5/335

Similar Items